• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

Oct 22
1:00 pm - 2:00 pm CDT

Les Turner ALS Foundation: The Access for ALL in ALS Consortium

Oct 27
2:00 pm - 3:00 pm EDT

ALS Association Webinar: An Honest Look at Hospice and ALS

Nov 2
2:00 pm - 3:00 pm EST

ALS Association Webinar: Caregiving, Connection & Meaningful Moments Series

View Calendar

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Hanne Stenmose, Denmark

    Hanne Stenmose, Denmark

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Liam Dwyer, England

    Liam Dwyer, England

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • David Hall, USA

    David Hall, USA

  • David Solomon, UK

    David Solomon, UK

  • Norm MacIsaac, Canada

    Norm MacIsaac, Canada

  • Daniel Hare, USA

    Daniel Hare, USA

  • Conny van der Meijden, Netherlands

    Conny van der Meijden, Netherlands

  • Purningam Jacob, India

    Purningam Jacob, India

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Philip Brindle, England

    Philip Brindle, England

  • John Dinon, Australia

    John Dinon, Australia

  • Lucy Lintott, Scotland

    Lucy Lintott, Scotland

  • Mauricio Dorin, Argentina

    Mauricio Dorin, Argentina

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • Dick Dayton, USA

    Dick Dayton, USA

  • Paul Launer, USA

    Paul Launer, USA

  • Irene McCaughey, Australia

    Irene McCaughey, Australia

  • Lombana, Spain

    Lombana, Spain

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Jean Waters, UK

    Jean Waters, UK

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Lee Millard, England

    Lee Millard, England

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Fayette Underwood, USA

    Fayette Underwood, USA

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Brian Lovell, Australia

    Brian Lovell, Australia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Greg Heydet, USA

    Greg Heydet, USA

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login